Published in

Foundation for Rehabilitation Information, Journal of Rehabilitation Medicine, 1(41), p. 13-25

DOI: 10.2340/16501977-0303

Links

Tools

Export citation

Search in Google Scholar

European consensus table on the use of botulinum toxin type A in adult spasticity.

Journal article published in 2009 by Anthony B. Ward, Jörg Wissel, Ward Ab, Martin J. Hecht, Thierry M. Lejeune ORCID, Maria C. Altavista, Per Erztgaard, Hecht Mj, Djamel Bensmail, Lejeune Tm, Stefano Cavazza, Thierry Deltombe, Altavista Mc, Alexander C. H. Geurts, Jean-Michel Gracies and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

A group of clinicians from across Europe experienced in the use of botulinum toxin type A for the treatment of spasticity following acquired brain injury gathered to develop a consensus statement on best practice in managing adults with spasticity. This consensus table summarizes the current published data, which was collated following extensive literature searches, their assessment for level of evidence and discussion among the whole group. Published information is supplemented by expert opinion based on clinical experience from 16 European countries, involving 28 clinicians, who treat an average of approximately 200 patients annually, representing many thousand spasticity treatments with botulinum toxin per year.